ACR2013: Biomarkers can predict pregnancy complications in lupus and antiphospholipid syndrome patients, and with some difficulty they also succeed at IVF.
ACR2013: Retrospective analysis of more than 10,000 pregnancies documents increased risks for hypertension, preeclampsia, preterm delivery and stillbirths among women with SLE.
ACR 2013: Stymied by high response rates in the "usual care" comparison arm of new-drug trials, lupus researchers are testing a bold idea: Carefully withdraw treatment from the control group.
ACR2013: As well as neonatal lupus and heart block, new research suggests that children born to women with lupus may face higher risks for autism and attention deficit hyperactivity disorder.
ACR 2013: Patients treated for IgG4-related disease with rituximab at Mass General and Mayo Clinic have shown rapid remission. Results also pointed to an important biomarker for the disorder.
ACR 2013: Debates about drug costs in rheumatoid arthritis dominated discussions at ACR this year, and one session was formally billed a debate. Will less-costly triple therapy someday be mandated for early RA?
ACR2013: Highly specific and sensitive for Sjögren's syndrome, ultrasound of the salivary gland can also benefit the accuracy of the new ACR criteria for the disorder.
ACR2013: Dual-energy computed tomography (DECT) proves a much clearer picture in complicated cases where gout may be challenging to diagnose.
ACR2013: Apremilast, a new kind of anti-inflammatory, proved significantly better than placebo against psoriatic arthritis after 52 weeks. Adverse effects were short-lived. Results for ustekinumab also held up after a year.
ACR2013: What clues suggest impending rheumatoid arthritis in a patient with stiffness and joint problems? A comparative study offers an answer, and another suggests that sleep problems are an important clue to severity of RA.